Immunogenicity and tolerability of an AdVac-based tuberculosis vaccine in BCG-naive subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2007
At a glance
- Drugs Tuberculosis vaccine (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Aeras; Crucell
- 13 Nov 2007 Results are expected in the first quarter of 2008.
- 31 Oct 2006 New trial record.